http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103705920-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-84 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
filingDate | 2013-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103705920-B |
titleOfInvention | Kytoplasm Polyadenylation component binding protein 4 vaccine and Synthesis and applications thereof |
abstract | The invention discloses a kind of kytoplasm Polyadenylation component binding protein 4 vaccine and Synthesis and applications thereof, this vaccine is ISCOM-DNA complex, its preparation method comprises the clone of kytoplasm Polyadenylation component binding protein 4 full-length cDNA, the clone of tumor necrosis factor BAFF full-length cDNA, the structure of recombinant vector pStar-CPEB4/BAFF, the structure of pStar-CPEB4/BAFF engineering bacteria, the abduction delivering of CPEB4, the preparation of ISCOM-DNA complex.This vaccine has a good application prospect in gliomatous control.The advantages such as the present invention has efficiently, low toxicity, preparation method are simple, can be used for the medicine of immunotherapy of tumors. |
priorityDate | 2013-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.